
Show Notes
This is a Premium-exclusive episode of the podcast. To listen to the full episode you need to be subscribed to Sigma Nutrition Premium. This episode examines dietary fiber through the lens of a practical, clinically relevant question: if higher fiber intakes are consistently associated with reduced chronic disease risk, what intake level should we be aiming for to meaningfully improve health outcomes? The discussion deliberately spans from common online claims that fiber is "not essential" (and therefore unnecessary), through to mechanistic reasoning and the highest-quality evidence we have for hard outcomes and accepted intermediate cardiometabolic endpoints. Across the episode, we'll hear from six expert perspectives to integrate epidemiology, controlled feeding studies, and clinical guideline contexts. We will consider how the dose–response patterns, fiber type/source, individual tolerance, and the limitations of nutrition trials all influence what can be recommended with confidence. Timestamps [03:51] Addressing the claim "fiber is not an essential nutrient" [11:23] Carbohydrate quality and fiber [17:16] Dietary recommendations for fiber [20:01] Portfolio diet and cardiovascular health [26:48] Comparing fiber sources [36:07] Epidemiological evidence on fiber [41:57] Understanding fiber intake and coronary heart disease [43:23] Fiber intake and colorectal cancer [54:06] Diet swap study: south african vs. african american diets [01:01:47] High fiber diets and diabetes [01:16:18] Challenges in fiber intake and IBS [01:21:45] Concluding thoughts on fiber intake Related Resources Subscribe to Sigma Nutrition Premium Go to episode page (with links to mentioned studies) Join the Sigma email newsletter for free Enroll in the next cohort of our Applied Nutrition Literacy course
More from Sigma Nutrition Radio
Can an athlete reduce the environmental impact of their diet while still meeting the demands of training, competition and recovery? Peter Res argues that these aims can be compatible, provided dietary changes are planned around the athlete's needs. The discussion looks at practical changes athletes can make to make their diets more environmentally sustainable. This includes tips on increasing the contribution of plant proteins, maintaining adequate energy intake, and making plant-rich eating practical within sporting environments. Timestamps
Men commonly feel that if their testosteone isn't "optimized" and high, they are missing out on greater health in a variety of ways. But what can a testosterone result actually tell us? How can results be interpreted with appropriate nuance that is needed? How low is low enough to be problematic? In situations where a test flags testosterone as low, there is a belief this means automatically starting testosterone replacement therapy. While TRT can be an excellent intervention in appropriate cases, when is it actually likely to benefit someone, and when is it not? For many people the decision seems straightforward: get a blood test, see whether testosterone is a little low, and start TRT. However, this simplistic thinking is full of potential issues that are important to understand. Dr. Austin Baraki returns to discuss how testosterone testing should inform treatment decisions, what benefits to expect, and the questions surrounding fertility and long-term safety. Timestamps:
Body composition testing is widely used in research, sport and clinical practice. But what are these methods actually measuring, and how much confidence should we place in the numbers they produce? In this episode, we examine the assumptions behind common approaches including DXA, bioelectrical impedance, and skinfold measurements. We discuss the distinction between accuracy and reliability, the value and limitations of repeated measurements, and how coaches, clinicians, researchers and individuals can select an appropriate method and interpret the data without overstating its precision. Joining Danny to discuss these issues is Professor Grant Tinsley, Professor of Human Performance at Texas Tech University and Director of its Energy Balance and Body Composition Laboratory. Timestamps:
Why do some foods feel difficult to stop eating, while others can be highly enjoyable without prompting the same tendency to overconsume? Answering this requires a clearer understanding of food reward, including the distinction between liking a food, wanting it, and perceiving it as easy to overeat. In this episode, we examine how nutritional composition, sensory characteristics, learned beliefs and the eating context may shape hedonic overeating. It also considers the limits of using broad food categories to explain complex eating behaviour. Discussing all this is Professor Graham Finlayson, professor of Psychobiology at the University of Leeds, whose research focuses on human appetite, food reward and the psychological processes involved in eating behaviour and weight control. Timestamps
Commonly people are talking about "peptides" to refer to a heterogeneous group of peptide medications or investigational compounds. These are increasingly promoted for injury recovery, tissue repair, performance and longevity, with BPC-157 attracting particular attention. But what evidence supports the claims made about these compounds? How should animal studies, biological mechanisms and personal anecdotes be interpreted? What is currently known about their safety? And what do recent regulatory discussions actually mean for their medical status and availability? In this episode, physician and Barbell Medicine founder Dr. Jordan Feigenbaum examines the evidence surrounding BPC-157 and other peptide medications, alongside the wider questions of risk, access and informed decision-making. Timestamps